AbbVie

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, and YouTube.

We are AbbVie. A global Fortune 500 biopharmaceutical company creating life-changing medicines and first-in-kind solutions that make a real difference in people’s lives.

Our 50,000+ employees across geographies, disciplines, and therapeutic areas put impact at the core of every decision. With over $50B invested in R&D since our founding in 2013, we’re always focused on helping people and communities thrive for generations to come.

1 North Waukegan Road
North Chicago, IL 60064

Tel: 1-800-255-5162

Visit website

Email Us

Stock Symbol: ABBV
Stock Exchange: NYSE

NEWS

Drug Development

Following Phase II Failure, Ironwood and AbbVie Halt Development of Delayed-Release Linzess

Ironwood and AbbVie said a Phase II trial assessing the drug candidate MD-7246, a delayed-release formulation of Linzess, did not meet its primary or key secondary endpoints.

May 29, 2020

2 min read

Alex Keown

Drug Development

Biotech Bay Companies Fighting Against COVID-19

Biotech Bay, the bustling biotech industry around San Francisco in California, is home to many biopharma companies developing diagnostics, therapies, and vaccines to fight against coronavirus disease 2019 (COVID-19) and the virus that causes it, called SARS-CoV-2.

May 22, 2020

11 min read

Chelsea Weidman Burke, M.S.

Bio NC

Clinical Catch-Up: May 11-15

Clinical trial updates not related to COVID-19 are on the upswing, partly because some companies are announcing trial information ahead of the upcoming American Society of Clinical Oncology virtual meeting being held at the end of the month. Here’s a look.

May 15, 2020

12 min read

Mark Terry

Drug Development

Biopharma Update on the Novel Coronavirus: May 11

Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for May 11, 2020.

May 11, 2020

4 min read

BioSpace Editorial Staff

Deals

One Step Closer: FTC Clears AbbVie and Allergan’s $63 Billion Merger

The U.S. Federal Trade Commission gave the green light to the $63 billion merger of AbbVie and Allergan. That leaves one last hurdle for the two companies, approval from the Irish High Court.

May 6, 2020

2 min read

Alex Keown

Job Trends

Clinical Catch-Up: April 20-24

Despite the domination of the news cycle by the COVID-19 pandemic, quite a number of biopharma companies reported on non-COVID-19 clinical trials last week, although there remains plenty of ongoing trial news related to the pandemic. Here’s a look.

April 24, 2020

10 min read

Mark Terry

FDA

Imbruvica-Rituximab Combo Approved by FDA for Chronic Lymphocytic Leukemia

The FDA recently approved the combination of Imbruvica-Rituximab for treating chronic lymphocytic leukemia. Here’s everything you need to know.

April 22, 2020

2 min read

Mark Terry

Insight Report: HIV and AIDS Research and Treatments

BioSpace takes an in-depth look at the human immunodeficiency virus including research, drugs in the pipeline and treatments. Check out the free downloadable report.

April 20, 2020

4 min read

Chelsea Weidman Burke, M.S.

Genetown

Genetown Hotbed: Churning Along During the COVID-19 Pandemic

As the biopharma industry responds to the COVID-19 pandemic, some of the area’s companies are at the very frontlines of drug development against the disease, while others play supporting roles for the entire industry. Here’s a look.

March 31, 2020

6 min read

Mark Terry

JOBS